- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 89.14M sh |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $17.93M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $28.41M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $18.26M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $28.87M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $216.14M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $189.43M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $219.68M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $193.63M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $0 |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $5.95M |
| Revenue | Q1 2025 · Mar 31, 2025 | $0 |
| Revenue | Q1 2025 · Mar 31, 2024 | $88.64M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $77.39M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $170.55M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 67.85M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $67K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$489K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $324.44M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $433.43M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$1.75 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$1.75 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $57.76M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $36.61M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$118.79M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$122.13M |